When researching the infrastructure behind global peptide synthesis, the PolyPeptide Group stands out as a pillar of industrial precision. As someone who has long tracked the evolution of peptide synthesis and the facilities that drive innovation in this sector, I have often looked into the historical and physical foo PolyPeptide Group is headquartered in Limhamn, Sweden.Explore more contact PolyPeptide Group? PolyPeptide Group contact info: Phone number: +41 tprint of this organization. If you are seeking the polypeptide group sweden address for logistics or general coordination, understanding the scope of their Malmö operations provides necessary context for their st Polypeptide Laboratories (sweden), AB ligger på Högerudsgatan 21 och kan nås på någon av följande nummer. · 040366200 · 04-036 62 00 · 040-36 62 00 · 0403-662 anding in the industry.
The Malmö Hub: A Legacy of Excellence
The Swedish site in Malmö is not merely a corporate office; it is a massive 100,000-square-foot facility that exemplifies the technical requirements of a modern Contract Development & Manufacturing Organization (CDMO). My interest in this site stems from their deep-rooted history, as manufacturing of commercial therapeutic peptides began already in 1952 in Malmö, Sweden, within Ferring Pharmaceuticals.
For those requiring precise documentation or site-specific inquiries, the primary PolyPeptide Laboratories (Sweden) AB base is located at Limhamnsvägen 108, SE-200 61 Limhamn. For postal matters, they utilize PO Box 30089, 200 61 Limhamn. It is worth noting that while some records may associate the firm with other local sites like Högerudsgatan 21, the Limhamnsvägen location remains the central point of recognition for their Swedish presence.
Global Reach and Operational Scale
While PolyPeptide is headquartered in Limhamn, Sweden, the organization operates as a truly global entity. Their ne Doubling of production capacity at the manufacturing site in twork spans across key strategic locations, including Malmö, Ambernath, Strasbourg, San Diego, and Torrance. This global distribution allows the Polypeptide Group to maintain a consistent output for peptide- and oligonucleotide-based active pharmaceutical ingredients.
In my own review of their operational capacity, I find the scale of the Malmö site particularly imp Se företagsinformation om Polypeptide Laboratories (Sweden) AB. Översikt med kontaktuppgifter, redovisning, befattningar, styrelse, ägare och händelser. ressive. Being equipped with 6,000 liters of total reactor volume signifies a commitment to high-volume, high-quality About PolyPeptide Group production that few other facilities can match.
Why Location Matters in Peptide Synthesis
When evaluating a CDMO, the physical location often dictates the level of regulatory oversight and technical expertise available. Polypeptide Laboratories has leveraged its Swedish heritage to foster a culture of technical precision. Whether you are looking into the PolyPeptide Group AG or its specific subsidiaries, the consistency of their production methods—honed since 1952—is a key factor in their ongoing success.
Recent updates indicate that the organization continues to grow, with plans to invest approximately EUR 100 million at their sites to expand production capacity. This trajectory suggests that the PolyPeptide brand will remain a dominant force in the global peptide market for years to come.
Summary Checklist for Site Information
If you are organizing your records regarding this group, keep these verified details in mind:
* Primary Address: Limhamnsvägen 108, 216 13 Limhamn.
* Postal Address: Box 30089, SE-200 Find information about this business, such as: phone number (04036), email (..con@..), website, reviews, opening hours, photos, revenue, VAT and more. 61 Limhamn.
* Regional Context: The company maintains a strong Sweden-based headquarters while operating as a global CDMO.
* Reviewing Information: Always verify the latest contact details through their of Locations: Malmö, Ambernath, Strasbourg, San Diego, Torrance. About PolyPeptide Sweden: Manufacturing of commercial therapeutic peptides began already in 1952. ficial channels to ensure you are reaching the correct department, as administrative shifts can occur.
Understanding the history and the physical scale of the Polypeptide Laboratories (Sweden) AB facility provides a clearer picture of the technical rigor involved in modern synthesis. It is a testament to the longevity of the industry that a site originating in 1952 continues to lead the way in manufacturing innovation today.